The Complex Strategic Landscape for Precision Medicine: Cost, Convergence, Culture, Computing and Creative Destruction

View more...

The Precision Medicine Initiative at Merck: State-of-the-Art Patient 68 Selection

View more...

Why diagnostic companies need to control their own market.

View more...

FDA and Precision Medicine 2017- An Interim Report from Washington

View more...

A conversation with Stephen J. Ubl President and CEO of PhRMA

View more...

Propelling Medicine into the Digital Age

View more...

California Paves the Way for State Efforts in Precision Medicine

View more...

Emerging Models for Clinical Adoption of Personalized Medicine

View more...

Understanding and Managing Stress: Perspectives from in vivo Quantum Biology

View more...

How to Align the Moving Parts in Personalized Medicine Reimbursement

View more...
Philips teams with 3D printing industry leaders 3D Systems and Stratasys

Philips teams with 3D printing industry leaders 3D Systems and…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced agreements with 3D Systems and Stratasys,…

Read More...
Definiens broadens Immuno-Oncology Service Offering

Definiens broadens Immuno-Oncology Service Offering

With the start of the 32nd Annual Meeting (November 8th-12th) of the Society for Immunotherapy of Cancer (SITC) in National…

Read More...
SeraCare Announces Industry’s First Comprehensive NGS Reference Material for Hematologic Malignancies

SeraCare Announces Industry’s First Comprehensive NGS…

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories,…

Read More...
Patrick Vallance, President, R&D, GSK to become UK Government’s Chief Scientific Adviser

Patrick Vallance, President, R&D, GSK to become UK Government’s…

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Dr Patrick Vallance, President, R&D, has informed the Board…

Read More...
University Hospital Bonn Announces New Technology To Advance Ability to Diagnose Rare Genetic Diseases in Children

University Hospital Bonn Announces New Technology To Advance…

The Institute for Genome Statistics and Bioinformatics, IGSB, and the Institute of Human Genetics, IHG, Bonn, have announced…

Read More...
Sema4 Appoints Fertility Expert Alan Copperman, MD, as Chief Medical Officer

Sema4 Appoints Fertility Expert Alan Copperman, MD, as Chief…

Sema4, a health information company providing advanced genomic testing, recently announced the appointment of Alan B. Copperman,…

Read More...
BioRad Sideline Sept 2017

Video

 Tweets